Galena Biopharma fka GALE

[Euripides90]

Excellent, thanks! This is for those who don't want to bother opening the link -- so if we hold we should at least triple is the "consensus" target.

Galena Biopharma Stock Rating Reaffirmed by Roth Capital (GALE)

Posted by Seth Barnet on Aug 25th, 2014 // 0 Comments
Share on StockTwits

Galena Biopharma Inc logoRoth Capital reissued their buy rating on shares of Galena Biopharma (NASDAQ:GALE) in a research report released on Thursday morning.

Separately, analysts at Needham & Company LLC cut their price target on shares of Galena Biopharma from $9.00 to $7.00 in a research note on Tuesday, August 12th. They now have a buy rating on the stock. One equities research analyst has rated the stock with a sell rating and six have given a buy rating to the stock. Galena Biopharma currently has an average rating of Buy and an average price target of $6.10.